A Scheme For A Dose-Escalation Study When The Event Is Lagged

STATISTICS IN MEDICINE(2002)

Cited 14|Views7
No score
Abstract
Classical designs for clinical phase I trials assume that information about a dose-limiting event (DLE) is available for all the included patients, or advise not to treat new patients until the information is present. If a DLE occurs after a lag, however, information at the current time might not be sufficient to make clear-cut decisions according to these designs. In particular, if new patients are available, it is not clear whether to include them in the trial. We suggest a rule that decides on the accrual of each individual eligible patient. Simulation studies are presented that indicate an advantage over the standard 'three-at-once' design in the length of the study. Copyright (C) 2001 John Wiley & Sons, Ltd.
More
Translated text
Key words
event,dose-escalation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined